Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Approval Evaluation of the PALMAZ MULLINS XD™ Pulmonary Stent in the Treatment of Pulmonary Artery Stenosis (REALPASS)

NCT07122518 is registered in ClinicalTrials.gov with Cordis US Corp. as lead sponsor.

NCT NCT07122518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07122518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Approval Evaluation of the PALMAZ MULLINS XD™ Pulmonary Stent in the Treatment of Pulmonary Artery Stenosis (REALPASS)
Lead sponsor
Cordis US Corp.
Phase
Observational
Overall status
Recruiting
Start date
June 23, 2026
Completion date
June 30, 2028
Enrollment
35 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary artery stenosis